Skip to main content
. 2018 Nov 16;1(7):e184741. doi: 10.1001/jamanetworkopen.2018.4741

Table 3. Subgroup Analysis by Unit Type on the Proportion of Prescribed Venous Thromboembolism Prophylaxis Medication Doses Misseda .

Intervention Period Surgical Units Medical Units
Intervention Group Control Group OR Intervention vs Control (95% CI) P Value Intervention Group Control Group OR Intervention vs Control (95% CI) P Value
Any Missed Dose
Preintervention, % (95% CI) 5.0 (3.1-8.2) 9.3 (6.8-12.6) 0.50 (0.26-0.98) .04 16.8 (10.3-27.2) 18.3 (14.1-23.8) 0.89 (0.47-1.69) .72
Postintervention, % (95% CI) 2.8 (1.7-4.6) 8.0 (5.9-10.8) 0.32 (0.16-0.63) .001 10.7 (6.6-17.3) 19.1 (14.8-24.7) 0.49 (0.26-0.92) .03
OR postintervention vs preintervention (95% CI) 0.54 (0.42-0.69) 0.84 (0.74-0.95) NA NA 0.58 (0.47-0.72) 1.06 (0.96-1.18) NA NA
P valueb <.001 .01 NA NA <.001 .24 NA NA
Patient Refusal
Preintervention, % (95% CI) 2.5 (1.3-4.9) 4.6 (3.0-6.9) 0.52 (0.22-1.25) .15 14.1 (7.6-26.4) 14.5 (10.4-20.3) 0.96 (0.44-2.13) .92
Postintervention, % (95% CI) 1.3 (0.6-2.6) 3.7 (2.5-5.5) 0.34 (0.14-0.81) .02 8.3 (4.4-15.4) 15.1 (10.8-21.0) 0.49 (0.22-1.08) .08
OR postintervention vs preintervention (95% CI) 0.50 (0.34-0.75) 0.79 (0.66-0.93) NA NA 0.54 (0.43-0.68) 1.05 (0.94-1.18) NA NA
P valueb <.001 .01 NA NA <.001 .36 NA NA
Other Reasons Than Refusal
Preintervention, % (95% CI) 2.3 (1.3-3.9) 3.8 (2.7-5.5) 0.56 (0.28-1.11) .10 2.2 (1.2-4.0) 3.1 (2.3-4.2) 0.71 (0.35-1.43) .34
Postintervention, % (95% CI) 1.3 (0.8-2.4) 3.5 (2.5-5.0) 0.37 (0.18-0.74) .01 2.1 (1.2-3.8) 3.3 (2.4-4.4) 0.63 (0.31-1.26) .19
OR postintervention vs preintervention (95% CI) 0.59 (0.44-0.80) 0.91 (0.78-1.06) NA NA 0.94 (0.64-1.37) 1.06 (0.89-1.26) NA NA
P valueb <.001 .23 NA NA .73 .49 NA NA

Abbreviations: NA, not applicable; OR, odds ratio.

a

Two-way interactions were performed including preintervention vs postintervention periods and control vs intervention units for surgical units (OR for any missed dose, 0.64 [95% CI, 0.48-0.85; P = .002]; OR for patient refusal, 0.64 [95% CI, 0.41-1.00; P = .05]; and OR for reasons other than refusal, 0.65 [95% CI, 0.47-0.91; P = .01]) and medical units (OR for any missed dose, 0.55 [95% CI, 0.44-0.69; P ≤ .001]; OR for patient refusal, 0.51 [95% CI, 0.39-0.66; P ≤ .001]; and OR for reasons other than refusal, 0.88 [95% CI, 0.57-1.35; P = .56]). Three-way interactions were performed including preintervention vs postintervention periods, control vs intervention units, and surgical vs medical unit with no significant differences observed (OR for any missed dose, 0.86 [95% CI, 0.60-1.23; P = .41]; OR for patient refusal, 0.80 [95% CI, 0.48-1.33; P = .38]; and OR for reasons other than refusal, 1.35 [95% CI, 0.78-2.33; P = .29]).

b

Calculated using multiple outputation of the generalized linear mixed-effects models with the binomial family and a logit link.